Results 91 to 100 of about 21,800 (268)
A procedure using low‐cost reagents to prepare allogeneic platelet gel from standard platelet units
Vox Sanguinis, EarlyView.Abstract Background and Objectives Highly effective procedures for the preparation of allogeneic platelet gel (PG) use Ca‐gluconate and batroxobin, an expensive commercial reagent. In this preliminary study, we explored the use of the plasmin‐inhibitor, low‐cost drug tranexamic acid (TXA) in place of batroxobin, based on the literature supporting TXA ...
Larysa Mykhailova +8 more
wiley +1 more source
Journal of Lipid Research, 2000 Epidemiologic studies and in vitro experiments indicate that low density lipoprotein (LDL) subtypes differ concerning their atherogenic potential. Small, dense LDL are more atherogenic than large, buoyant LDL.
B.M. Schamberger +4 more
doaj
Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin's lymphoma [PDF]
, 1995 RS Negrin +9 more
openalex +1 more source
Vox Sanguinis, EarlyView.Abstract Background and Objectives Maximizing the potency of cord blood (CB) units (CBU) is a goal of all CB banks. Low transplant cell dose in CB transplantation is one of several contributors to the slower engraftment. Processing delays could also be at play because CBU can be stored at room temperature (RT) for up to 48 h before cryopreservation. We
Suria Jahan +6 more
wiley +1 more source
Clinical Pharmacology &Therapeutics, Volume 117, Issue 5, Page 1413-1426, May 2025.Platelet reconstitution after allogeneic hematopoietic cell transplantation (allo‐HCT) is heterogeneous and influenced by various patient‐ and transplantation‐related factors, associated with poor prognoses for poor graft function (PGF) and isolated thrombocytopenia.
Katharina M. Götz +23 more
wiley +1 more source
Use of Angiotensin (AII) antagonist losartan in patient treated with DSC LDL-apheresis. [PDF]
, 1999 P. Maxia +4 more
openalex +1 more source
Transfusion Medicine and Hemotherapy, 2019 Behrouz Mansouri Taleghani +1 more
openaire +2 more sources
Clinical Case Reports, Volume 13, Issue 4, April 2025.ABSTRACT Paraneoplastic (p) TTP is a rare syndrome characterized by an immune‐induced, generalized microangiopathy associated with solid or hematological tumors. This case, reporting a patient with a metastatic HER2+ breast cancer and a pTTP, highlights the rarity of this entity, its difficult and challenging diagnosis, and the complexity of its ...
Raffaele Longo +9 more
wiley +1 more source
Clinical Findings of Long-Term Treatment with LDL-Apheresis
, 1989 Masaki Shinomiya +16 more
openalex +2 more sources
Caplacizumab treatment in elderly patients with iTTP: Experience from the Spanish TTP Registry
HemaSphere, Volume 9, Issue 4, April 2025.Abstract Immune thrombotic thrombocytopenic purpura (iTTP) typically affects middle‐aged individuals, although it sometimes appears in older patients. Caplacizumab is approved for the treatment of iTTP, but information on the safety and efficacy of this drug in elderly patients is not available.
Inés Gómez‐Seguí +20 more
wiley +1 more source